Patients infected with HIV type 1 subtype CRF01-AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine

Weerawat ManosuthiDavid M. ButlerWasun ChantratitaChonlaphat SukasemDouglas D. RichmanDavey M. SmithThailand Ministry of Public HealthMahidol UniversityUniversity of California, San DiegoVA Medical Center2018-09-242018-09-242010-06-01AIDS Research and Human Retroviruses. Vol.26, No.6 (2010), 609-611088922292-s2.0-77954203618https://repository.li.mahidol.ac.th/handle/20.500.14594/29232Mahidol UniversityImmunology and MicrobiologyMedicinePatients infected with HIV type 1 subtype CRF01-AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirineLetterSCOPUS10.1089/aid.2009.0107